- Home
- RDHL vs RELI Comparison
RDHL vs RELI Comparison
Compare RDHL & RELI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDHL
- RELI
- Stock Information
- Founded
- RDHL 2009
- RELI 2013
- Country
- RDHL Israel
- RELI United States
- Employees
- RDHL N/A
- RELI N/A
- Industry
- RDHL Biotechnology: Pharmaceutical Preparations
- RELI Specialty Insurers
- Sector
- RDHL Health Care
- RELI Finance
- Exchange
- RDHL Nasdaq
- RELI Nasdaq
- Market Cap
- RDHL 3.8M
- RELI 3.5M
- IPO Year
- RDHL N/A
- RELI N/A
- Fundamental
- Price
- RDHL $1.99
- RELI $1.47
- Analyst Decision
- RDHL
- RELI
- Analyst Count
- RDHL 0
- RELI 0
- Target Price
- RDHL N/A
- RELI N/A
- AVG Volume (30 Days)
- RDHL 214.4K
- RELI 41.1K
- Earning Date
- RDHL 04-10-2025
- RELI 07-24-2025
- Dividend Yield
- RDHL N/A
- RELI N/A
- EPS Growth
- RDHL N/A
- RELI N/A
- EPS
- RDHL N/A
- RELI N/A
- Revenue
- RDHL $8,042,999.00
- RELI $14,208,143.00
- Revenue This Year
- RDHL $381.91
- RELI N/A
- Revenue Next Year
- RDHL N/A
- RELI N/A
- P/E Ratio
- RDHL N/A
- RELI N/A
- Revenue Growth
- RDHL 23.17
- RELI 2.40
- 52 Week Low
- RDHL $1.71
- RELI $0.97
- 52 Week High
- RDHL $20.28
- RELI $18.53
- Technical
- Relative Strength Index (RSI)
- RDHL 51.03
- RELI 68.56
- Support Level
- RDHL $1.82
- RELI $1.29
- Resistance Level
- RDHL $1.93
- RELI $1.56
- Average True Range (ATR)
- RDHL 0.08
- RELI 0.09
- MACD
- RDHL 0.04
- RELI 0.03
- Stochastic Oscillator
- RDHL 100.00
- RELI 80.00
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
About RELI Reliance Global Group Inc.
Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.